Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
alnylam pharmaceuticals
amgen
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alopecia areata
amarin
arena pharmaceuticals
What
drug
3
×
market
3
×
fda
patients
advantages
bar
bio
bringing
brings
cancer
cholesterol
clears
closer
eisai
expect
filing
flags
gamble
higher
inched
incidence
lorcaserin
loss
lowering
marketing
medco
medco’s
medicine
medicines
morning
mover
new
payers
phase
physicians
plan
positive
post
preps
pricing
Language
unset
Current search:
market
×
drug
×
" national top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
